Pharmaceutical Executive February 13, 2025
Polypharmacy, biosimilars, and GLP-1s among the evolving trends likely to play out in the pharmacy benefits space.
The pharmacy benefits industry is gearing up for significant change in the coming years. Projections point to a dramatic surge to $875 billion by 2026, constituting 15.4% of the nation’s healthcare budget.1 As 2025 unfolds, we expect to see several trends play out in the pharmacy industry, including the escalation of medicine costs, rising polypharmacy, the growing use of GLP-1 agonists for obesity, and expanding biosimilar adoption. The changes necessitate innovative strategies to manage costs while upholding care quality.
The polypharmacy conundrum
Polypharmacy, the simultaneous use of multiple medications (typically five or more) by one patient, has become the norm for many Americans,...
Today's Sponsors
Today's Sponsor